October Community Roundtable to be held October 25 from 4:00 – 5:30 p.m. ET
Are you interested in learning the latest on the following:
- Clinical data exchange; coverage, transparency and burden
- Quality and risk use cases
- The HL7 Da Vinci Project’s Implementation Guide foundational assets?
If so, register now for the next Da Vinci Community Roundtable, to be held Oct. 25 from 4:00 – 5:30 p.m. ET. The session will offer timely updates on changes made in 2023 to the Da Vinci Implementation Guides and offer an outlook for next year.
“The Power of Collaboration: 2023 HL7 Da Vinci Project Implementation Guide Progress,” will feature presenters discussing Implementation Guide functional enhancements as well as the current status and maturity of the guides to help inform your planning for next year’s HL7 Fast Healthcare Interoperability Resources (HL7® FHIR®) implementation staffing and allocations. Attendees will also learn where they can provide needed input and participation in the use cases.
The Da Vinci Project is a private-sector initiative that accelerates the adoption of HL7 FHIR as the standard to support and integrate value-based care (VBC) data exchange across communities. The goal of the project is to help payers and providers positively impact clinical, quality, cost and care management outcomes, enabling providers to see the right data at the right time for patient-centered care.
The presenters will include:
- Michael Gould, Associate Vice President, Interoperability Strategy, ZeOmega and HL7 Da Vinci Project Architectural Group Co-Lead
- Crystal Kallem, Project Manager, HL7 Da Vinci Project, and Senior Consultant, Point-of-Care-Partners
- Mark Scrimshire, PDex Project Lead & Implementation Guide Lead, HL7 Da Vinci Project, and Chief Interoperability Officer, Onyx Health
- Teresa Younkin, Value Based Performance Reporting Co-Lead, HL7 Da Vinci Project PMO and Senior Consultant, Point-of-Care Partners
The session is moderated by Alix Goss, HL7 Da Vinci Project PMO, and Senior Consultant, Point-of-Care Partners.